Skip to content

Comparison of Hip Resurfacing to Large Femoral Head Total Hip Arthroplasty

Femoral Head Resurfacing Versus a Large Femoral Head (Durom®) Total Hip System: A Prospective Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00175487
Enrollment
56
Registered
2005-09-15
Start date
2007-09-30
Completion date
2014-06-30
Last updated
2014-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Osteoarthritis

Keywords

Osteoarthritis/Avascular Necrosis, Hip

Brief summary

This study evaluates femoral head resurfacing versus a large femoral head (Durom®) total hip system. This is a prospective randomized trial.

Interventions

PROCEDUREHip replacement

This study evaluates femoral head resurfacing versus a large femoral head (Durom®) total hip system. This is a prospective randomized trial.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Indication for hip resurfacing because of osteoarthritis or avascular necrosis 2. Aged 19 to 65 years old 3. Ability to give informed consent

Exclusion criteria

1. Previous fracture requiring internal fixation of the hip 2. Previous hip osteotomy (pelvic or femoral) 3. Dysplasia requiring structural bone graft 4. Inability to respond to questionnaires in English (or French, Montreal centre only) 5. The presence of osteopenia or osteoporosis 6. Evidence of hepatic/renal insufficiency or failure from medical history or laboratory assessment

Design outcomes

Primary

MeasureTime frame
To estimate the difference in postoperative quality of life between patients with Durom® hip resurfacing versus those with total hip arthroplasty (THA) using a large-head, metal-on-metal articulationat 2 years

Secondary

MeasureTime frame
To estimate the difference in concentrations of cobalt and chromium ions in serum
To estimate the difference in gait (pelvic tilt, forward velocity, and cadence)at 12 and 52 weeks
To estimate the lower limb functional instability by a test of postural balance

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026